Skip to content

Metabolic syndrome management by Asanadi ghanavati and lifestyle modification

TO EXPLORE METABOLIC SYNDROME IN AYURVEDIC PARLANCE AND ITS MANAGEMENT by ASANADI GHANAVATI ALONG WITH LIFE STYLE MODIFICATION-AN OPEN LABELLED SINGLE ARM CLINICAL TRIAL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018351
Enrollment
60
Registered
2019-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E898- Other postprocedural endocrine andmetabolic complications and disorders

Interventions

Intervention1: ASANADIGHANA VATI ONLY ONE GROUP: 4 TABLET 500MG OF ASANADI GHANAVATI THREE TIMES AFTER MEAL WITH LUKE WARM WATER Intervention2: ASANADI GHANAVATI: 4 TAB. THREE TIME A DAY FOR THREE MON

Sponsors

IPGTRA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS HAVING ANY THREE SIGN-SYMPTOM OF METABOLIC SYNDROME

Exclusion criteria

Exclusion criteria: PATIENTS HAVING LESS THAN 30 AND MORE THAN 60 YEARS PATIENTS IS TAKING TREATMENT FOR DM-HYPERTENSION-DYSLIPIDAEMIA PATIENTS OF ISCHAEMIC HEART DISEASE OR HAVING HISTORY OF MYOCARDIAL INFARCTION WITHIN LAST SIX MONTH PATIENTS NOT WILLING TO PARTICIPATE IN THE STUDY

Design outcomes

Primary

MeasureTime frame
IMPROVEMENT IN OBJECTIVE CRITERIA WAIST CIRCUMFERENCE,BLOOD PRESSURE,LIPID PROFILE,FBS. OF METABOLIC SYNDROMETimepoint: IMPROVEMENT IN OBJECTIVE CRITERIA WAIST CIRCUMFERENCE,BLOOD PRESSURE,LIPID PROFILE,FBS. OF METABOLIC SYNDROME

Secondary

MeasureTime frame
SUBJECTIVE IMPROVEMENTTimepoint: SUBJECTIVE IMPROVEMENT

Countries

India

Contacts

Public ContactDr Darshna Pandya

IPGT AND RA

darshnapandya73@gmail.com9099011095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026